10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Obesity among Asian American people in the United States: A review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Standard measures of obesity, i.e., body weight and BMI, suggest that Asian American people have a lower obesity prevalence than other racial groups in the United States. However, Asian American people face a unique challenge in their pattern of adiposity with central obesity, which raises the risk for multiple comorbidities, such as type 2 diabetes, metabolic syndrome, and cardiovascular disease, at a lower BMI compared with other populations. Several organizations recommend lower BMI cutoffs for obesity in Asian people (BMI ≥25.0 or ≥27.5 kg/m 2) instead of the standard ≥30.0 kg/m 2 threshold. The risks of obesity and related comorbidities in this population are further influenced by diet, physical activity, perceptions of health, and access to information and therapies. Asian‐specific parameters for assessing obesity should become a standard part of clinical practice. Asian American people should equally be offered subgroup‐specific tailored interventions owing to heterogeneity of this population. Access to medications and surgery should be improved, in part by updating US indications for therapies to reflect race‐specific obesity thresholds and through inclusion of Asian American people of all subtypes with lower BMI values in clinical trials.

          Abstract

          Related collections

          Most cited references73

          • Record: found
          • Abstract: found
          • Article: not found

          Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

          (2004)
          A WHO expert consultation addressed the debate about interpretation of recommended body-mass index (BMI) cut-off points for determining overweight and obesity in Asian populations, and considered whether population-specific cut-off points for BMI are necessary. They reviewed scientific evidence that suggests that Asian populations have different associations between BMI, percentage of body fat, and health risks than do European populations. The consultation concluded that the proportion of Asian people with a high risk of type 2 diabetes and cardiovascular disease is substantial at BMIs lower than the existing WHO cut-off point for overweight (> or =25 kg/m2). However, available data do not necessarily indicate a clear BMI cut-off point for all Asians for overweight or obesity. The cut-off point for observed risk varies from 22 kg/m2 to 25 kg/m2 in different Asian populations; for high risk it varies from 26 kg/m2 to 31 kg/m2. No attempt was made, therefore, to redefine cut-off points for each population separately. The consultation also agreed that the WHO BMI cut-off points should be retained as international classifications. The consultation identified further potential public health action points (23.0, 27.5, 32.5, and 37.5 kg/m2) along the continuum of BMI, and proposed methods by which countries could make decisions about the definitions of increased risk for their population.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

            (2020)
            The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

              Despite decades of unequivocal evidence that waist circumference provides both independent and additive information to BMI for predicting morbidity and risk of death, this measurement is not routinely obtained in clinical practice. This Consensus Statement proposes that measurements of waist circumference afford practitioners with an important opportunity to improve the management and health of patients. We argue that BMI alone is not sufficient to properly assess or manage the cardiometabolic risk associated with increased adiposity in adults and provide a thorough review of the evidence that will empower health practitioners and professional societies to routinely include waist circumference in the evaluation and management of patients with overweight or obesity. We recommend that decreases in waist circumference are a critically important treatment target for reducing adverse health risks for both men and women. Moreover, we describe evidence that clinically relevant reductions in waist circumference can be achieved by routine, moderate-intensity exercise and/or dietary interventions. We identify gaps in the knowledge, including the refinement of waist circumference threshold values for a given BMI category, to optimize obesity risk stratification across age, sex and ethnicity. We recommend that health professionals are trained to properly perform this simple measurement and consider it as an important ‘vital sign’ in clinical practice.
                Bookmark

                Author and article information

                Contributors
                zli@mednet.ucla.edu
                Journal
                Obesity (Silver Spring)
                Obesity (Silver Spring)
                10.1002/(ISSN)1930-739X
                OBY
                Obesity (Silver Spring, Md.)
                John Wiley and Sons Inc. (Hoboken )
                1930-7381
                1930-739X
                25 January 2023
                February 2023
                : 31
                : 2 ( doiID: 10.1002/oby.v31.2 )
                : 316-328
                Affiliations
                [ 1 ] Center for Human Nutrition, UCLA Los Angeles California USA
                [ 2 ] Penn State Health Camp Hill Philadelphia USA
                [ 3 ] Scripps Clinic Del Mar San Diego California USA
                [ 4 ] Hartford Healthcare Medical Group Glastonbury Connecticut USA
                Author notes
                [*] [* ] Correspondence

                Zhaoping Li, Center for Human Nutrition, UCLA, Los Angeles, California, USA.

                Email: zli@ 123456mednet.ucla.edu

                Author information
                https://orcid.org/0000-0002-8662-4310
                Article
                OBY23639
                10.1002/oby.23639
                10108164
                36695056
                0bdb3b10-007a-42d3-8f22-588f87c63432
                © 2023 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 10 October 2022
                : 15 June 2022
                : 27 October 2022
                Page count
                Figures: 2, Tables: 3, Pages: 13, Words: 10207
                Funding
                Funded by: Novo Nordisk Inc., Plainsboro, New Jersey, USA
                Categories
                Review
                REVIEWS
                Epidemiology/Genetics
                Custom metadata
                2.0
                February 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:17.04.2023

                Medicine
                Medicine

                Comments

                Comment on this article